Abstract
Parkinson’s disease affects about one in a hundred of the UK population over the age of 60, with a total of 60–80,000 recognized cases. The extent of false-negative diagnosis is not known, but at least one-third of parkinsonian patients are said to receive an incorrect initial diagnosis14. Similarly, in one-third of the patients, there has been a more than three-year delay in making the diagnosis after the initial symptoms. This suggests that diagnosis other than Parkinson's disease have been considered17. In addition, recent surveys have indicated that perhaps a third of all established cases in the community may be unrecognized. A four-fold difference in disease prevalence has been reported from different countries, but accurate statistics for the worldwide incidence of Parkinson’s disease are not available.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Andrews, K. Rehabilitation of conditions associated in old age. Int. Rehabil. Med. 1985; 7: 125–129.
Beattie, A. and Caird, F.I. The occupational therapist and the patient with Parkinson's disease. Br. Med. J. 1980; 280: 1354–1355.
Brown, R.G. and MacCarthy, B. Social, psychological and physical factors in Parkinson's disease. Paper presented at the British Psychological Society London Conference. December 1985.
Cassileth, B.R., Lusk, E.J., Strouse, T.B. et al. Psychosocial status in chronic illness-a comparative analysis of six diagnostic groups. N. Engl. J. Med. 1984; 311: 506–511.
Critchley, E.M.R. Peak dose dysphonia in parkinsonism. Lancet 1976; i: 544.
Davis, J.C. Team management of Parkinson's disease. Am. J. Occup. Ther. 1977; 31: 300–308.
Gibbard, F.B., Page, N.G., Spencer, K.M. et al. Controlled time of physiotherapy and occupational therapy for Parkinson's disease. Br. Med. J. 1981; 282: 1196.
Godwin-Austin, R.B., Tomlinson, E.B., Frears, C.C. et al. Effects on l-dopa in Parkinson's disease. Lancet. 1969; 2: 165–168.
Gotham, A.M., Brown, R.G. and Marsden, C.D. Depression in Parkinson's disease: a quantitative and qualitative analysis. J. Neurol. Neurosurg. Psychiat. 1986; 49: 381–389.
Hoehn, M.M. and Yahr, M.D. Parkinsonism: onset, progression and mortality. Neurology 1967; 17: 427–442.
Hunt, S.M., McEwen, J. and McKenna, S.P. Measuring health status: a new tool for clinicians and epidemiologists. R. J. Coll. Gen. Pract. 1985; 35: 155–158.
Kennard, C., Munro, A.J. and Park, D.M. The reliability of clinical assessment of Parkinson's disease. J. Neurol. Neurosurg. Psychiat. 1984; 47: 322–323.
Knuttson, N. An analysis of parkinsonian gait. Brain 1972; 95: 475–486.
Lees, A.J. Early diagnosis of Parkinson's disease. Br. J. Hosp. Med. 1981; 26: 511–518.
Manson, L. and Caird, F.I. Survey of the hobbies and transport of patients in Parkinson's disease. Occ. Ther. 1985; 7: 199–200.
Marsden, C.D. and Parkes, J.D. ‘On-off’ effects in patients with Parkinson's disease on chronic levodopa. Lancet 1976; 1: 292–296.
Marttila, R.J. Epidemiological, clinical and virus-serological studies of Parkinson's disease. Reports from the Department of Neurology, University of Turku, No.6, Turku, 1974.
Mawdsley, C. and Gamsu, C.V. Periodicity of speech in Parkinson's disease.Nature 1971; 231: 315–316.
Oxtoby, M. Parkinson's Disease Patients and their Social Needs. Parkinson's Disease Society publication, 1982.
Quinn, N., Marsden, C.D. and Parkes, J.D. Complicated response fluctuations in Parkinson's disease: response to intravenous infusion of levodopa. Lancet 1982; 2: 412–415.
Robins, A.H. Depression in patients with parkinsonism. Br. J. Psychiat. 1976; 128: 141–145.
Robbins, J.A., Logemann, J.A. and Kirshner, H.S. Swallowing and speech production in Parkinson's disease. Ann. Neurol. 1986; 285–287.
Robertson, S.J. and Thomson, F. Speech therapy in Parkinson's disease: a study of the efficacy and long term effects of intensive treatment. Br. J. Dis. Commun. 1900; 19: 213–224.
Rubow, R. and Swift, E. A microcomputer-based wearable biofeedback device to improve transfer of treatment in parkinsonian dysarthria. J. Speech Hear. Disord. 1985; 50: 178–185.
Scott, S., Caird, F.I. and Williams, I. Speech therapy for Parkinson's disease. J. Neurol. Neurosurg. Psychiat. 1983; 46: 140–144.
Scott, S. and Caird, F.I. The response of the apparent receptive speech disorder of Parkinson's disease to speech therapy. J. Neurol. Neurosurg. Psychiat. 1984; 47: 302–304.
Singer, E. The social costs of Parkinson's disease. J. Chronic Dis. 1973; 26: 243–254.
Sutcliffe, R.L., Prior, R., Mawby, B. and McQuillan, W.J. Parkinson's disease in the district of the Northampton Health Authority (UK): a study of prevalence and disability. Acta Neurol. Scand. 1985; 72: 363–379.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Shindler, J.S., Brown, R., Welburn, P., Parkes, J.D. (1993). Measuring the quality of life of patients with Parkinson’s disease. In: Walker, S.R., Rosser, R.M. (eds) Quality of Life Assessment: Key Issues in the 1990s. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-2988-6_16
Download citation
DOI: https://doi.org/10.1007/978-94-011-2988-6_16
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-5328-0
Online ISBN: 978-94-011-2988-6
eBook Packages: Springer Book Archive